165 related articles for article (PubMed ID: 24131626)
1. 'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'.
Havnes IA; Clausen T; Middelthon AL
Harm Reduct J; 2013 Oct; 10():24. PubMed ID: 24131626
[TBL] [Abstract][Full Text] [Related]
2. Execution of control among 'non-compliant', imprisoned individuals in opioid maintenance treatment.
Havnes IA; Clausen T; Middelthon AL
Int J Drug Policy; 2014 May; 25(3):480-5. PubMed ID: 24594221
[TBL] [Abstract][Full Text] [Related]
3. Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms.
Johnson B; Richert T
J Subst Abuse Treat; 2015 Jul; 54():50-5. PubMed ID: 25744650
[TBL] [Abstract][Full Text] [Related]
4. The paradox of control: An ethnographic analysis of opiate maintenance treatment in a Norwegian prison.
Mjåland K
Int J Drug Policy; 2015 Aug; 26(8):781-9. PubMed ID: 26025481
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S
Addiction; 2012 Mar; 107(3):501-17. PubMed ID: 21955033
[TBL] [Abstract][Full Text] [Related]
6. Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients.
Launonen E; Alho H; Kotovirta E; Wallace I; Simojoki K
Int J Drug Policy; 2015 Sep; 26(9):875-82. PubMed ID: 25934054
[TBL] [Abstract][Full Text] [Related]
7. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.
Johnson B; Richert T
Int J Drug Policy; 2015 Feb; 26(2):183-90. PubMed ID: 25465344
[TBL] [Abstract][Full Text] [Related]
8. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Johnson B; Richert T
Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
[TBL] [Abstract][Full Text] [Related]
9. Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.
Richert T; Johnson B
Harm Reduct J; 2013 Oct; 10():27. PubMed ID: 24139199
[TBL] [Abstract][Full Text] [Related]
10. Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.
Vijay A; Bazazi AR; Yee I; Kamarulzaman A; Altice FL
J Subst Abuse Treat; 2015 Jul; 54():29-36. PubMed ID: 25841703
[TBL] [Abstract][Full Text] [Related]
11. The role of substance use and morality in violent crime - a qualitative study among imprisoned individuals in opioid maintenance treatment.
Havnes IA; Clausen T; Brux C; Middelthon AL
Harm Reduct J; 2014 Aug; 11():24. PubMed ID: 25142321
[TBL] [Abstract][Full Text] [Related]
12. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
Holland R; Maskrey V; Swift L; Notley C; Robinson A; Nagar J; Gale T; Kouimtsidis C
Addiction; 2014 Apr; 109(4):596-607. PubMed ID: 24304349
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
Maas J; Barton G; Maskrey V; Pinto H; Holland R
Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
Lugoboni F; Zamboni L; Cibin M; Tamburin S;
Eur Addict Res; 2019; 25(1):10-19. PubMed ID: 30625491
[TBL] [Abstract][Full Text] [Related]
15. The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.
Mravčík V; Janíková B; Drbohlavová B; Popov P; Pirona A
Harm Reduct J; 2018 Dec; 15(1):60. PubMed ID: 30514306
[TBL] [Abstract][Full Text] [Related]
16. Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.
Bukten A; Herskedal A; Skurtveit S; Bramness JG; Clausen T
Addiction; 2013 Nov; 108(11):1954-61. PubMed ID: 23773400
[TBL] [Abstract][Full Text] [Related]
17. Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective.
Johnson B; Richert T
J Psychoactive Drugs; 2014; 46(5):427-35. PubMed ID: 25364995
[TBL] [Abstract][Full Text] [Related]
18. The diversion and injection of a buprenorphine-naloxone soluble film formulation.
Larance B; Lintzeris N; Ali R; Dietze P; Mattick R; Jenkinson R; White N; Degenhardt L
Drug Alcohol Depend; 2014 Mar; 136():21-7. PubMed ID: 24461476
[TBL] [Abstract][Full Text] [Related]
19. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
[TBL] [Abstract][Full Text] [Related]
20. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
Guan Q; Khuu W; Spithoff S; Kiran T; Kahan M; Tadrous M; Martins D; Leece P; Gomes T
Drug Alcohol Depend; 2017 Aug; 177():315-321. PubMed ID: 28733101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
